Ambucaine
- Level
- Commodity
- Parent
- 51271900
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51271902This classification denotes an anesthetic agent with the molecular formula C17H28N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M7G4B57ZCB, chemically known as benzoic acid, 4-amino-2-butoxy-, 2-(diethylamino)ethyl ester but generally known as ambucaine, which bears US NIH Compound Identifier 8387. European Medicines Agency schedules Ambucaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05399MIG. The term AMBUCAINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, No. 12, 1959, List 3). AMBUCAINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ambucaine under HS 29225000 and SITC 51467. As of Q4 2014, AMBUCAINE remains the US FDA Preferred Term for this commodity. Ambucaine bears US NLM identifiers UMLS ID C2346730 and NCI Concept Code C72165. SMILES: O(CCN(CC)CC)C(=O)C1C(OCCCC)CC(N)CC1.
Same parent
Under 51271900 · 24Activities that produce or sell this
KBLI · 8Inherited from family 51270000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.